VR Logo

Syngene International Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: Kiran Mazumdar Shaw

Managing Director: Jonathan Hunt

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 19,668.00 Cr

Revenue (TTM): R 2,012.60 Cr

Earnings (TTM): R 398.10 Cr

Cash: R 1,019.90 Cr

Total Debt: R 685.60 Cr

Promoters' ownership: 70.65%

Liquidity: High

52 Week range: R 212.55 - 504.20

Face value: R10.00

Shares outstanding: 40,00,00,000

10 Years Aggregate:

  • CFO: 3,098.70 Cr
  • EBITDA: 3,197.30 Cr
  • Net Profit: 2,084.70 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD50.4946.26-3.66
1 month9.4818.537.64
3 months52.6928.6226.23
1 Year52.9454.375.46
3 Years29.8815.39-0.76
5 Years--2.334.52
10 Years--13.466.63
As on 10-Aug-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis